我科于1996年开始对收治的Ⅱ～Ⅲ期食管癌患者进行随机分组,一组采用同步DF方案化疗加超分割放疗,一组单纯放射治疗,同时与我院外科收治的Ⅱ～Ⅲ期食管癌患者进行比较,现将结果报告如下: 1 材料 所有病例均为经组织细胞学证实的Ⅱ～Ⅲ期食管癌病人,采取随机分组的方法分为化放疗同步组及单纯放疗组,手术组即符合手术条件的Ⅱ～Ⅲ期食管癌病人。 化放疗同步组及单放组的入组条件:①年龄<70岁,性别不限,KPS≥80分。②组织学证实为鳞 Our department in 1996 began to treat patients with stage Ⅱ ~ Ⅲ esophageal cancer were randomized to a group of patients with synchronous DF regimen plus hyperfractionated radiotherapy, a group of simple radiotherapy, and surgical treatment of our hospital Ⅱ ~ Ⅲ esophagus Cancer patients were compared, the results are reported as follows: 1 Materials All cases were confirmed by histological cytology Ⅱ ~ Ⅲ esophageal cancer patients, randomized divided into the group of concurrent chemotherapy and radiotherapy group, the surgical group that Meet the surgical conditions of Ⅱ ~ Ⅲ esophageal cancer patients. Radiotherapy and radiotherapy group and single release group of the conditions: ① age <70 years, gender is not limited, KPS ≥ 80 points. ② histologically confirmed as scales